Microbial keratitis in Thailand: a survey of common practice patterns.

OBJECTIVE To describe the current practice patterns and prescription preferences in treating microbial keratitis in Thailand. MATERIAL AND METHOD A questionnaire was designed and sent to ophthalmologists to describe their practice in patients with microbial keratitis. The questionnaire also presented two case scenarios with microbial keratitis; the less severe in the first patient and the more severe in the second. The recipients were asked about their diagnostic and therapeutic approaches. The surveys were mailed to 300 ophthalmologists around the country. RESULTS One hundred and forty-three surveys (48.6%) were used in the analysis. Over half the respondents (56%) would do corneal scraping for some patients with suspected microbial keratitis. Smears and cultures of corneal specimens are the most common diagnostic tools (92%) to identify the causative organisms. Of the respondents, 60% would treat Case 1 as an outpatient, compared with 90% would admit Case 2. About half the respondents (47%) would initiate treatment in Case 1 without obtaining scrapings, whereas 79% would prefer microbial work up in Case 2. Monotherapy with topical fluoroquinolone was the most common initial antibiotic prescribed for Case 1 (36%), whereas in Case 2, combined fortified antibiotics (23%) and combined topical antibiotic and topical antifungal (22%) were preferred. For fungal keratitis, topical natamycin and amphotericin B were the most common choices (20% each). CONCLUSIONS Most Thai ophthalmologists appear to treat patients with suspected microbial keratitis differently, depending on etiology and severity. However, there are some variations in management. The validity of this approach should be established to specify patterns that are most safe and effective.

[1]  H. Taylor,et al.  Microbial Keratitis: Predisposing Factors and Morbidity , 2006 .

[2]  A. Maden,et al.  Severe fungal keratitis treated with subconjunctival fluconazole. , 2005, American journal of ophthalmology.

[3]  A. Romano,et al.  Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. , 2004, American journal of ophthalmology.

[4]  N. Tananuvat,et al.  MICROBIAL KERATITIS LEADING TO ADMISSION AT MAHARAJ NAKORN CHIANG MAI HOSPITAL , 2004 .

[5]  C. McGhee,et al.  Severe infective keratitis leading to hospital admission in New Zealand , 2003, The British journal of ophthalmology.

[6]  L. Laroche,et al.  Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases , 2003, The British journal of ophthalmology.

[7]  G. Johnson,et al.  Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis , 2002, The British journal of ophthalmology.

[8]  P. Paul,et al.  Intracameral Amphotericin B Injection in the Management of Deep Keratomycosis , 2002, Cornea.

[9]  N. Kasetsuwan,et al.  Infectious keratitis at King Chulalongkorn Memorial Hospital: a 12-year retrospective study of 391 cases. , 2002, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[10]  L. Zografos,et al.  Bacterial keratitis: a prospective clinical and microbiological study , 2001, The British journal of ophthalmology.

[11]  H. Taylor,et al.  Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. , 2001, American journal of ophthalmology.

[12]  G. Alexandrakis,et al.  Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. , 2000, Ophthalmology.

[13]  H. Taylor,et al.  Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers , 2000, The British journal of ophthalmology.

[14]  Savitri Sharma,et al.  Ciprofloxacin-resistant Pseudomonas keratitis. , 1999, Ophthalmology.

[15]  J. Baum,et al.  Emerging fluoroquinolone resistance in bacterial keratitis: A 5-year review , 1999 .

[16]  W. Benson,et al.  Current diagnosis and treatment of corneal ulcers. , 1998, Current Opinion in Ophthalmology.

[17]  I. C. Lloyd,et al.  Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group. , 1996, Ophthalmology.

[18]  J. Krachmer,et al.  Cornea and external disease : clinical diagnosis and management , 1997 .

[19]  D. Fong,et al.  Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. , 1996, Archives of ophthalmology.

[20]  P. McDonnell,et al.  The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. , 1996, Ophthalmology.

[21]  M. Maguire,et al.  Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. , 1995, Archives of ophthalmology.

[22]  J. Dart,et al.  Strategies for the management of microbial keratitis. , 1995, The British journal of ophthalmology.

[23]  R. Arffa Grayson's Diseases of the Cornea , 1991 .